Kristen M Oelschlager Castle Biosciences Inc (CSTL) insider trading activity

Kristen M Oelschlager is Chief Operating Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 152,522 shares of CSTL, which is worth approximately $4.2 Million. The most recent transaction as insider was on Dec 10, 2024, when has been sold 2,156 shares (Common Stock) at a price of $29.63 per share, resulting in proceeds of $63,882. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

13.11% 3M change

10.77% 12M change

Total Value Held $4.2 Million

Kristen M Oelschlager Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Payment of exercise price or tax liability	$63,882 $29.63 p/Share	2,156 Reduced 1.39%	152,522 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	7,919 Added 4.89%	154,148 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$130,007 $30.91 p/Share	4,206 Reduced 2.79%	146,759 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	15,961 Added 9.56%	150,965 Common Stock
Sep 03 2024	SELL Open market or private sale	$171,985 $29.49 p/Share	5,832 Reduced 4.15%	134,841 Common Stock
Aug 09 2024	SELL Payment of exercise price or tax liability	$75,231 $26.83 p/Share	2,804 Reduced 1.95%	140,673 Common Stock
Aug 09 2024	BUY Grant, award, or other acquisition	-	10,641 Added 6.9%	143,477 Common Stock
Aug 01 2024	SELL Open market or private sale	$301,864 $23.24 p/Share	12,989 Reduced 8.91%	132,836 Common Stock
Jul 29 2024	SELL Open market or private sale	$61,613 $22.06 p/Share	2,793 Reduced 1.88%	145,825 Common Stock
Jul 01 2024	SELL Open market or private sale	$59,267 $21.22 p/Share	2,793 Reduced 1.84%	148,618 Common Stock
Dec 29 2023	BUY Exercise of conversion of derivative security	$34,186 $2.71 p/Share	12,615 Added 7.74%	150,302 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$42,114 $20.17 p/Share	2,088 Reduced 1.49%	137,687 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	7,920 Added 5.42%	138,149 Common Stock
Dec 09 2023	SELL Payment of exercise price or tax liability	$84,835 $20.17 p/Share	4,206 Reduced 3.09%	131,855 Common Stock
Dec 09 2023	BUY Exercise of conversion of derivative security	-	15,961 Added 10.5%	136,061 Common Stock
Dec 28 2022	BUY Exercise of conversion of derivative security	$17,155 $2.39 p/Share	7,178 Added 5.69%	118,914 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$52,094 $22.32 p/Share	2,334 Reduced 2.05%	111,736 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	7,920 Added 6.52%	113,554 Common Stock
Apr 26 2022	BUY Grant, award, or other acquisition	-	6,692 Added 5.95%	105,873 Common Stock
Dec 10 2021	SELL Payment of exercise price or tax liability	$20,908 $40.52 p/Share	516 Reduced 0.52%	98,774 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	-	1,750 Added 1.73%	99,290 Common Stock
Sep 27 2021	SELL Open market or private sale	$712,300 $71.23 p/Share	10,000 Reduced 9.3%	97,540 Common Stock

KMO

Kristen M Oelschlager

Chief Operating Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account